Cardiac RadiothErapy for VEntricular Tachycardia II
ConditionVentricular Tachycardia (VT)
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversitaire Ziekenhuizen KU Leuven
About this trial
Steoreotactic therapy radioablation has become a standard of care option for patients with therapy-refractory ventricular tachycardia, yet long-term outcome is lacking. The objective of this study is to evaluate the long-term outcomes, both efficacy and safety, after STAR in patients with therapy-refractory ventricular tachycardia.
Eligibility criteria
Qualifiers
Eligible for STAR for therapy-refractory VT based on a multidisciplinary discussion
Ability to give a written informed consent and willingness to return for follow-up
Disqualifiers
Contra-indications for STAR, including pregnancy or breastfeeding, previous radiotherapy with cardiac involvement, life-expectancy < 6 months in the absence of VT
Any condition that is deemed a contraindication in the judgment of the investigators
Trial design
Treatments tested in this trial
- stereotactic radiotherapy ablation
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov